Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(24):1855; doi:10.1093/jnci/dji445
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Popat, S.
Right arrow Articles by Houlston, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Popat, S.
Right arrow Articles by Houlston, R. S.
Related Collections
Right arrowResponse to this Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

CORRESPONDENCE

Re: Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)

Sanjay Popat, Richard S. Houlston

Affiliations of authors: Kent Oncology Centre, Maidstone Hospital, Kent, U.K. (SP); Section of Cancer Genetics, Institute of Cancer Research, Sutton, U.K. (RSH)

Correspondence to: Sanjay Popat, BSc, MB, MRCP, PhD, Kent Oncology Centre, Maidstone Hospital, Kent ME16 9QQ, U.K. (e-mail: sanjay.popat@icr.ac.uk).

The first 10% of the full text of this article appears below.

We warmly welcome the National Cancer Institute-European Organisation for Research and Treatment of Cancer (NCI-EORTC) reporting guidelines for tumor marker prognostic studies (REMARK) recently reported in the Journal (1). We believe the authors are correct to point out the inadequacies in reporting . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Response to this Correspondence

RESPONSE: Re: Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei, Sheila E. Taube, Massimo Gion, and Gary M. Clark
J Natl Cancer Inst 2005 97: 1855-1856. [Extract] [Full Text] [PDF]